Yield10 Bioscience Begins Winter 2022/2023 Field Test and Seed Production Program
November 10 2022 - 8:30AM
Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the
“Company”), an agricultural bioscience company, today announced
that the Company has begun its winter 2022/2023 field test and seed
production program for Camelina at sites in the United States,
Canada, Argentina and Chile.
Program Highlights
Yield10’s winter 2022/2023 field test program, which is being
conducted at more than 20 sites, is intended to evaluate several
varieties of elite Camelina by collecting data on agronomical
performance, seed yield, oil content, and herbicide tolerance,
where applicable.
Herbicide Tolerance: Yield10 is
conducting contra-season field tests of candidate herbicide
tolerance traits in Camelina. Building on encouraging, initial
results generated in spring 2022, Yield10 is advancing the
development of spring Camelina with tolerance to over-the-top
herbicide used for broadleaf weed control. Yield10 has selected
potential commercial events of Camelina lines displaying herbicide
tolerance and will evaluate field performance and conduct seed
scale-up activities for producing seed for larger field tests
planned for spring 2023.
Agronomy Trials: Yield10 will conduct agronomy
trials of winter Camelina varieties as part of a program to develop
standardized protocols to achieve the best germination, stand
establishment and yields. As part of this program, the Company is
evaluating the winter hardiness of its Camelina varieties WDH2 and
WDH3 as compared to winter wheat in various geographies.
Commercial Seed Production: Yield10 has
contracted with growers to plant Camelina varieties E3902 (spring,
high oil), WDH3 (winter, early maturing) and WDH2 (winter, cold
tolerant) to produce commercial seed. This activity is intended to
increase commercial inventory of Camelina seed available for
growers’ contracts for future planting of Camelina used to produce
low-carbon intensity feedstock oil for the biofuel market and
high-protein meal for the animal feed market.
Demonstration Fields: As part of its market
development efforts, Yield10 has planted winter Camelina in fields
suitable for hosting grower events in 2023.
“Our goal is to develop industry-leading, high-performing elite
winter and spring Camelina varieties that offer the grower new
opportunities for crop diversification as well as important
sustainability benefits,” said Kristi Snell, Ph.D., Chief
Science Officer of Yield10 Bioscience. “Our field tests, which are
designed to evaluate herbicide tolerance in Camelina, and our
related seed scale-up activities are key elements of our winter
2022-2023 field program.”
“Our commercial seed production activities currently underway in
the U.S. and Canada are expected to provide us with winter Camelina
seed inventory to enable ramping up grower engagement and securing
grower contracts in 2023 and beyond,” said Darren Greenfield,
Senior Director, Seed Operations of Yield10 Oilseeds. “Over the
last several months, we have also secured contra-season seed
production capabilities in Chile for production of spring
Camelina. Availability of this seed is intended to support
planting in spring 2023.”
About Yield10 Bioscience
Yield10 Bioscience, Inc. is an agricultural bioscience company
that is using its differentiated trait gene discovery platform, the
“Trait Factory”, to develop improved Camelina varieties for the
production of proprietary seed products, and to discover high value
genetic traits for the agriculture and food industries. Our goals
are to efficiently establish a high value seed products business
based on developing superior varieties of Camelina to produce
biofuel feedstock oils, PHA bioplastics and omega-3 (DHA+EPA) oils
and to license our yield traits to major seed companies for
commercialization in major row crops, including corn, soybean and
canola. Yield10 is headquartered in Woburn, MA and has an Oilseeds
Center of Excellence in Saskatoon, Canada.
For more information about the company, please visit
www.yield10bio.com, or follow the Company on Twitter, Facebook and
LinkedIn.
(YTEN-G)
Safe Harbor for
Forward-Looking Statements
This press release contains forward-looking statements which are
made pursuant to the safe harbor provisions of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. The forward-looking
statements in this release do not constitute guarantees of future
performance. Investors are cautioned that statements in this press
release which are not strictly historical, including, without
limitation, the Company’s plans, expectations and intended results
from the 2022/2023 field test program; the Company’s intention to
produce commercial inventory of Camelina seed; the Company’s goals
related to the development of Camelina varieties; and the Company’s
expectations related to ramping up grower engagement and securing
grower contracts, constitute forward-looking
statements. Such forward-looking statements are subject to a number
of risks and uncertainties that could cause actual results to
differ materially from those anticipated, including the risks and
uncertainties detailed in Yield10 Bioscience's filings with the
Securities and Exchange Commission. Yield10 assumes no obligation
to update any forward-looking information contained in this press
release or with respect to the matters described herein.
Contacts: Yield10 Bioscience:Lynne H. Brum,
(617) 682-4693, LBrum@yield10bio.com
Investor Relations: Bret Shapiro, (561) 479-8566,
brets@coreir.comManaging Director, CORE IR
Media Inquiries: Eric Fischgrund, eric@fischtankpr.com FischTank
PR
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Apr 2023 to Apr 2024